Better Times Ahead For Corvus Pharmaceuticals Inc (NASDAQ: CRVS)?
Corvus Pharmaceuticals Inc (CRVS) concluded trading on Thursday at a closing price of $3.35, with 4.1 million shares of worth about $13.74 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -62.86% during that period and on May 08, 2025 the price saw a […]
